Jump to contents

Researcher Information

last modified:2017/11/21

Professor YAMAMOTO Yasuhiko

Mail Laboratory Website

Faculty, Affiliation

Faculty of Medicine, Institute of Medical, Pharmaceutical and Health Sciences Department of Biochemistry and Molecular Vascular Biology

College and School Educational Field

Division of Medical Sciences, Graduate School of Medical Science
Division of Cardiovascular Medicine, Graduate School of Medical Science
School of Medicine, College of Medical, Pharmaceutical and Health Sciences

Laboratory

Department of Biochemistry and Molecular Vascular Biology, Kanazawa University Graduate School of Medical Science TEL:076-265-2181 FAX:076-234-4217

Academic Background

【Academic background(Doctoral/Master's Degree)】
Kanazawa University Doctor 199603 Completed
【Academic background(Bachelor's Degree)】
Kanazawa University School of Medicine 199203

Career

JSPS Research Associate Dept. Biochem, Kanazawa Univ. Sch. Med.(1997/09-1999/03)
Kanazawa University School of Medicine Instructor(1999/04-2001/03)
Kanazawa University Graduate School of Medical Science(2001/04-2006/06)
金沢大学 Graduate School of Medical Science(2006/07-2012/04)
Joslin Diabetes Center & Harvard Medical School Visiting Scientist(2006/10-2009/08)
Kanazawa University Graduate School of Medical Sciences(2012/05-2015/04)
Kanazawa University(2015/05-)

Year & Month of Birth

1968/03

Academic Society



JMARS
International Maillard Reaction Society (IMARS)

Anti-Aging Medicine
Japanese Society of Internal Medicine





Award



○Japan Diabetic Complication Society Young Investigator Award(2008/10/03)
○Sr. Iacocca Visiting Scientist Award(2007/05/08)
○Sumitomo Life Social Welfare Foundation(2006/09/27)
○Japan Diabetes Foundation(2004/11/26)
○Young Investigator Award, Japan Biochemical Society Hokuriku Branch(2003/05/31)
○Young Investigator Award, Japan Biochemical Society Hokuriku Branch(2003/05/31)
○Young Investigator Award, Japan Biochemical Society Hokuriku Branch(2003/05/31)

Specialities

General medical chemistry、Pathological medical chemistry

Speciality Keywords

Cellmetabolism, Diabetic vascular complications, Immunity, Neuroendocine

Research Themes

Inflammation in obesity

Cell metabolism and diseases

Molecular mechanism for development of diabetic vascular complications

Innate immunity

Books

  •  RAGE as a functional receptor for AGE CMC Publishers 2010/12
  •  AGE receptors Asakura
  •  AGE-RAGE system in diabetic vascular complications Nipponrinshosha Co., Ltd. 68 増刊 39-44 2010/11
  •  Identification of mouse ortholog of endogenous secretory receptor for advanced glycation endproducts: structure, function and expression. 396 1  109-115 2006/01
  •  A severe diabetic nephropathy model with early development of nodule-like lesions induced by megsin overexpression in the RAGE/ iNOS transgenic mice. 55  356-366 2006

show all

  •  Development of an ELISA for esRAGE and its application to type 1 diabetic patients. 73  158-165 2006
  •  Deletion of RAGE causes hyperactivity and increased sensitivity to auditory stimuli in mice. 4 12 e8309 2009
  •  Isoflavones inhibit nicotine C-oxidation catalyzed by human CYP2A6. 46 3  337-344 2006/03
  •  Expression profiling of endogenous secretory receptor for advanced glycation end products in human organs. 18 10  1385-1396 2005/10

Papers

  •  Deletion of RAGE causes hyperactivity and increased sensitivity to auditory stimuli in mice 4 12 8309 2009/12
  •  Blockade of endothelial-mesenchymal-transition by a Smad3 inhibitor delays the early development of streptozotocin-induced diabetic nephropathy. DIABETES 2010
  •  Regulation of alternative splicing of the receptor for advanced glycation endproducts (RAGE) through G-rich cis-elements and heterogenous nuclear ribonucleoprotein (hnRNP) H. JOURNAL OF BIOCHEMISTRY 147 5 651-659 2010
  •  Inhibition of allergic bronchial asthma by thrombomodulin is mediated by dendritic cells. AMERICAN JOURNAL OF RESPIRATORY AND CRITICAL CARE MEDICINE 2010
  •  Spontaneous bone loss in RIP-iNOS transgenic mouse: A mouse model for diabetes- mediated osteopenia/osteoporosis. Cell Cycle 8 24 4179-4181 2009

show all

  •  Glycation of a food allergen by the Maillard reaction enhances its T-cell immunogenicity: the role of macrophage scavenger receptor class A type I and II. JOURNAL OF ALLERGY AND CLINICAL IMMUNOLOGY 125 1 175-183 2010
  •  RAGE mediates oxidized LDL-induced pro-inflammatory effects and atherosclerosis in non-diabetic LDL receptor-deficient mice. CARDIOVASCULAR RESEARCH 82 2  371-381 2009/02
  •  The solution structure of variable-type domain of receptor for advanced glycation endproducts: a new insight into AGE-RAGE interaction. BIOCHEMISTRY 47 47  12299-12311 2008
  •  Neural activity dependent release of S100B from astrocytes enhances kainite-induced gamma oscillations in vivo. JOURNAL OF NEUROSCIENCE 28 43  10928-10936 2008
  •  Reduced expression of endogenous secretory receptor for advanced glycation endproducts in hippocampal neurons of Alzheimer's disease brains. ARCHIVES OF HISTOLOGY AND CYTOLOGY 70 5  279-290 2007/05
  •  De-N-glycosylation or G82S mutation of RAGE sensitizes its interaction with advanced glycation endproducts. BIOCHIMICA ET BIOPHYSICA ACTA-GENERAL SUBJECTS 1770 10  1468-1474 2007/10
  •  Assaying soluble forms of receptor for advanced glycation endproducts. ARTERIOSCLEROSIS THROMBOSIS AND VASCULAR BIOLOGY 27  33-34 2007
  •  The role of the receptor for advanced glycation end-products in lung fibrosis. AMERICAN JOURNAL OF PHYSIOLOGY-LUNG CELLULAR AND MOLECULAR PHYSIOLOGY 2007/06
  •  Endogenous secretory receptor for advanced glycation end-products as a novel prognostic marker in chondrosarcoma. CANCER 109 12  2532-2540 2007/12
  •  Short-chain aldehyde-derived ligands for RAGE and their actions on endothelial cells. DIABETES RESEARCH AND CLINICAL PRACTICE S1  30-40 2007/01
  •  Inhibition of diabetic leukostasis and blood-retinal barrier breakdown with a soluble form of a receptor for advanced glycation end products. INVESTIGATIVE OPHTHALMOLOGY & VISUAL SCIENCE 48 2  858-865 2007/02
  •  Endogenous secretory receptor for advanced glycation endproducts levels are correlated with serum pentosidine and CML in patients with type 1 diabetes. ARTERIOSCLEROSIS THROMBOSIS AND VASCULAR BIOLOGY 27 1  253-254 2007/01
  •  Endogenous secretory receptor for advanced glycation end products in non-small cell lung carcinoma. AMERICAN JOURNAL OF RESPIRATORY AND CRITICAL CARE MEDICINE 175 2  184-189 2007/02
  •  Receptor for advanced glycation endproducts is involved in impaired angiogenic response in diabetes. DIABETES 55 8  2245-2255 2006/08
  •  RAGE control of diabetic nephropathy in a mouse model: effects of RAGE gene disruption and administration of low molecular weight heparin. DIABETES 55 9  2510-2522 2006/09
  •  Plasma level of endogenous secretory receptor for advanced glycation endproducts (esRAGE) is associated with components of the metabolic syndrome and atherosclerotic arterial wall thickness. ARTERIOSCLEROSIS THROMBOSIS AND VASCULAR BIOLOGY 25 12  2587-2593 2005/12
  •  RAGE is a promising target of diabetic nephropathy. ANNALS OF THE NEW YORK ACADEMY OF SCIENCES 1013 1-5 2005/06
  •  The N-terminal domain of thrombomodulin sequesters high mobility group-B1. JOURNAL OF CLINICAL INVESTIGATION 115 1267-1274 2005/05
  •  Possible participation of pICln in the regulation of angiogenesis through alternative splicing of VEGF receptor mRNAs. ENDOTHELIUM-NEW YORK 11 5-6 293-300 2004
  •  AGE downregulation of monocyte expression of RAGE mRNA and its association with diabetic complications in type 1 diabetes. JOURNAL OF DIABETES AND ITS COMPLICATIONS 18 53-60 2004/01
  •  Advanced glycation end products increase collagen-specific chaperone protein in mouse diabetic nephropathy. JOURNAL OF BIOLOGICAL CHEMISTRY 279 19816-19823 2004/04
  •  Identification of a novel AGE-capturable soluble variant of the RAGE in human sera. Excerpta Medical International Congress Series 163-167 2002/10
  •  RAGE engagement and vascular cell derangement by short chain sugar-derived advanced glycation endproducts. Excerpta Medical International Congress Series 129-135 2002/10
  •  The role of AGE-RAGE system in the development of diabetic nephropathy in vivo. Excerpta Medica International Congress Series 45-50 2002/10
  •  Advanced glycation endproduct-induced calcium handling impairment in mouse cardiac myocytes. JOURNAL OF MOLECULAR AND CELLULAR CARDIOLOGY 34 1425-1431 2002/10
  •  Novel splice variants of the RAGE expressed in human vascular endothelial cells and pericytes, and their putative roles in diabetes-induced vascular injury. BIOCHEMICAL JOURNAL 370 3 1097-1109 2003/03
  •  AGE-deriven angiogenesis in vitro: induction of the growth and tube formation of human microvascular endothelial cells through autocrine VEGF. JOURNAL OF BIOLOGICAL CHEMISTRY 272 13 8723-8730 1997/04
  •  The regulation of soluble receptor for AGEs contributes to carbonyl stress in schizophrenia Miyashita M, Watanabe T, Ichikawa T, Toriumi K, Horiuchi Y, Kobori A, Kushima I, Hashimoto R, Fukumoto M, Koike S, Ujike H, Arinami T, Tatebayashi Y, Kasai K, Takeda M, Ozaki N, Okazaki Y, Yoshikawa T, Amano N, Washizuka S, Yamamoto H, Miyata T, Itokawa M, Yamamoto Y, Arai M Biochemical and Biophysical Research Communications 2016
  •  Targeting of RAGE-ligand signaling impairs breast cancer cell invasion and metastasis Hudson B, Kwak TY, Drews-Elger K, Ergonul A, Braley A, Zhao D, Besser A, El-Ashry D, Slingerland J, Lippman M, Miller P, Yamamoto Y, Yamamoto H, Hwang G Oncogene 2016
  •  Clinical relevance of peroxisome proliferator-activated receptor-gamma expression in myxoid liposarcoma Takeuchi A, Yamamoto N, Shirai T, Hayashi K, Miwa S, Munesue S, Yamamoto Y, Tsuchiya H BMC Cancer 16 442 2016/07
  •  Atf6α deficiency suppresses microglial activation and ameliorates pathology of experimental autoimmune encephalomyelitis Ta H, Le T, Ishii H, Takarada-Iemata M, Hattori, T, Hashida K, Yamamoto Y, Mori K, Takahashi R, Kitao Y, Hori O J Neurochem 2016/10
  •  Cyclic ADP-ribose and heat regulate oxytocin release via CD38 and TRPM2 in the hypothalamus during social or psychological stress in mice Zhong J, Amina S, Liang M, Akther S, Yuhi T, Nishimura T, Higashida C, Tsuji T, Liu HX, Hashii M, Furuhara K, Yokoyama S, Yamamoto Y, Okamoto H, Zhao YJ, Lee HC, Tominaga M, OLopatina O, Higashida H Front Neurosci 10 304 2016/10
  •  Adipose natural killer cells regulate adipose tissue macrophages to promote insulin resistance in obesity Lee BC, Kim MS, Pae M, Yamamoto Y, Eberlé D, Shimada T, Kamei N, Park HS, Sasorith S, Woo JR, You J, Mosher W, Brady HJM, Shoelson SE, Lee J Cell Metab 23 4 685-698 2016/04
  •  Modulation of leukotriene B4 receptor 1 signaling by RAGE Ichiki T, Koga T, Okuno T, Saeki K, Yamamoto Y, Yamamoto H, Sakaguchi M, Yokomizo T FASEB J 30 5 1811-1822 2016/05
  •  Tumor-associated macrophages of the M2 phenotype contribute to progression in gastric cancer with peritoneal dissemination Yamaguchi T, Fushida S, Yamamoto Y, Tsukada T, Kinoshita J, Oyama K, Miyashita T, Tajima H, Ninomiya I, Munesue S, Harashima A, Harada S, Yamamoto H, Ohta T Gastric Cancer 2015/11
  •  The receptor for advanced glycation end-products is associated with apoptosis of alveolar epithelial cells in hyperoxia exposure in vitro and in vivo Ota C, Ishizawa K, Yamada M, Tando Y, Mei H, Takahashi T, Yamamoto Y, Yamamoto H, Kubo H Respiratory Invest 54 2 98-108 2016/02
  •  Epidermal expression of receptor for advanced glycation end-products (RAGE) is related to inflammation and apoptosis in human skin Iwamura M, Yamamoto Y, Kitayama Y, Higuchi K, Fujimura T, Hase T, Yamamoto H Exp Dermatology 25 3 235-237 2016/03
  •  RAGE mediates the interactivation of nAChRs in sympathetic neurons during high glucose conditions Chandna AR, Baskaran MN, Chang C, Pennington PR, Mousseau DD, Yamamoto Y, Campanucci VA Eur J Neurosci 41 3 341-351 2015/03
  •  Gadd34 regulates liver regeneration in hepatic steatosis Inaba Y, Furutani T, Kimura K, Watanabe H, Haga S, Kido Y, Yamamoto Y, Harada K, Kaneko S, Oyadomari S, Ozaki M, Kasuga M, Inoue H Hepatology 61 4 1343-1356 2015/04
  •  Emphysema requires the receptor for advanced glycation end products triggering on structural cells Waseda K, Miyahara N, Taniguchi A, Kurimoto E, Ikeda G, Koga H, Fujii U, Yamamoto Y, Gelfand EW, Yamamoto H, Tanimoto M, Kanehiro A Am J Respir Cell Mol Biol 52 4 482-491 2015/04
  •  Contrasting Roles for the Receptor for Advanced Glycation End-Products on Structural Cells in Allergic Airway Inflammation versus Airway Hyperresponsiveness Taniguchi A, Miyahara N, Waseda K, Kurimoto E, Fuji U, Tanimoto Y, Kataoka M, Yamamoto, Y, Gelfand E, Tanimoto M, Yamamoto H, Kanehiro A Am J Physiol Lung Cell Mol Physiol 309 8 L789-800 2015/08
  •  Thrombomodulin modulates dendritic cells via both antagonism of high mobility group protein B1 and an independent mechanism Toda M, D'Alessandro-Gabazza CN, Takagi T, Chelakkot-Govindalayathila AL, Taguchi O, Roeen Z, Munesue S, Yamamoto Y, Yamamoto H, Gabazza EC, Morser J Allergology Int 63 1 57-66 2014/01
  •  Maltitol endows foods with lower 3-deoxyglucosone content and less RAGE agonism as a sweetener against sucrose Kuretani A, Kawamura R, Munesue S, Yamamoto Y, Honda J, Yamamoto H Glycative Stress Res 1 2 25-31 2014/02
  •  Glycyrrhizin inhibits traumatic brain injury in rats by reducing HMGB1-RAGE interaction Okuma Y, Liu K, Wake H, Liu R, Nishimura Y, Hui Z, Teshigawara K, Haruma J, Yamamoto Y, Yamamoto H, Date I, Takahashi HK, Mori S, Nishibori M Neuropharmacology 85 18-26 2014/07
  •  cAMP ameliorates inflammation in macrophages by modulation of receptor for advanced glycation end-products Motoyoshi S, Yamamoto Y, Munesue S, Igawa H, Harashima A, Saito H, Han H, Watanabe T, Sato H, Yamamoto H Biochem J 463 1 72-82 2014/01
  •  Longistatin secreted with tick saliva blocks RAGE Anisuzzaman, Hatta T, Miyoshi T, Mtsubayashi M, Islam MK, Alim MA, Anas MA, Hasan MM, Matsumoto Y, Yamamoto Y, Yamamoto H, Fujisaki K, Tsuji N J Clin Invest 124 10 4429-4444 2014/10
  •  Expression of RAGE by tumor macrophages promotes angiogenesis in gliomas Chen X, Zhang L, Zhang IY, Liang J, Wang H, Ouyang M, Wu S, da Fonseca ACC, Weng L, Yamamoto Y, Yamamoto H, Natarajan R, Badie B Cancer Res 74 24 7285-7297 2014/08
  •  Sivelestat sodium hydrate inhibits neutrophil migration to the vessel wall and suppresses hepatic ischemia-reperfusion injury Sakai S, Tajima H, Miyashita T, Nakanuma SI, Makino I, Hayashi H, Nakagawara H, Kitagawa H, Fushida S, Fujimura T, Saito H, Munesue S, Yamamoto Y, Ohta T Dig Dis Sci 59 4 787-794 2014/04
  •  Alteration of energy metabolism in the pathogenesis of bile duct lesions in primary biliary cirrhosis Harada K, Kakuda Y, Sato Y, Ikeda H, Shimoda S, Yamamoto Y, Inoue H, Ohta H, Kasashima S, Kawashima A, Nakanuma Y J Clin Pathol  67 5 396-402 2014/05
  •  CD38 in the nucleus accumbens and oxytocin are related to paternal behavior in mice Akther S, Korshnova N, Zhong J, Liang M, Cherepanov SM, Lopatina O, Komleva YK, Salmina AB, Nishimura T, Fakhrul AAKM, Hirai H, Kato I, Yamamoto Y, Takasawa S, Okamoto H, Higashida H Mol Brain 6 41 2013/06
  •  Regulation of diet-induced adipose tissue and systemic inflammation by salicylates and pioglitazone Kim MS, Yamamoto Y, Kim K, Kamei N, Shimada T, Liu L, Moore K, Woo JR, Shoelson SE, Lee J PLoS ONE 8 12 e82847 2013/08
  •  Roles of the AGE-RAGE system in vascular injury in diabetes. Ann. N. Y. Acad. Sci. 902 163-172 2000/05
  •  Vascular endothelial growth factor acts as a pericyte mitogen under hypoxic conditions. Lab. Invest. 79 4 501-509 1999/04
  •  The receptor for advanced glycation endproducts is induced by the glycation products themselves and TNF-a through NF-kB, and by 17b-estradiol through Sp-1 in human vascular endothelial cells. J. Biol. Chem. 275 33 25781-25790 2000/08
  •  Relationship between interindividual differences of nicotine metabolism and CYP2A6 genetic polymorphism in humans. Clin. Pharmacol. Ther. 69 1 72-78 2001/01
  •  Placenta growth factor and vascular endothelial growth factor B and C expressions in microvascular endothelial cells and pericytes: implication in autocrine and paracrine regulation of angiogenesis. J. Biol. Chem. 274 49 35172-35178 1999/12
  •  Molecular heterogeneity of the receptor for advanced glycation endproducts. J. Biochem. Mol. Biol. Biophys. 4 373-381 2000
  •  Insulin stimulates the growth and tube formation of human microvascular endothelial cells through autocrine vascular endothelial growth factor. Microvasc. Res. 57 3 329-339 1999/05
  •  Development and prevention of advanced diabetic nephropathy in RAGE-overexpressing mice. J. Clin. Invest. 108 2 261-268 2001/07
  •  CD38 disruption impairs glucose-induced increases in cyclic ADP-ribose, [Ca2+]i,and insulin secretion. J. Biol. Chem. 274 4 1869-1872 1999/01
  •  Advanced glycation endproducts inhibit prostacyclin production and induce plasminogen activator inhibitor-1 in human microvascular endothelial cells. DIABETOLOGIA 41 12 1435-1441 1998/12
  •  Antisense display - A new method for functional gene screen and its application to angiogenesis-related gene isolation. Ann. N. Y. Acad. Sci. 947 382-386 2001/12
  •  Receptor-mediated toxicity to pericytes of advanced glycosylation end products: a possible mechanism of pericyte loss in diabetic microangiopathy. BIOCHEMICAL AND BIOPHYSICAL RESEARCH COMMUNICATIONS 213 2 681-687 1995/02
  •  Advanced glycosylation end products could not only stimulate the growth , but also inhibit the prostacyclin-producing ability of endothelial cells. FEBS LETTERS 384 103-106 1996/02
  •  Inhibitory effect of cyclosporin A on prolactin synthesis in GH3 cells. TOHOKU JOURNAL OF EXPERIMENTAL MEDICINE 180 337-346 1996/02
  •  The first case of IDDM with prominent spurious hyperglucagonemia due to interference of IgG in glucagon RIA (OAL-123). HORMONE RESEARCH 45 295-299 1996/03
  •  Advanced glycation endproducts-receptor interactions stimulate the growth of human pancreatic cancer cells through the induction of PDGF-B. BIOCHEMICAL AND BIOPHYSICAL RESEARCH COMMUNICATIONS 222 3 700-703 1996/07
  •  Spinal cord compression by heterotopic ossification associated with Pseudohypoparathyroidism. JOURNAL OF INTERNATIONAL MEDICAL RESEARCH 25 364-368 1997/03

Conference Presentations

  • RAGE: a pattern-recognition receptor(conference:12th International congress on amino acids, peptides and proteins)(2011/08/01)
  • RAGE: a pattern-recognition receptor(conference:International Guest Lecture for the Scientific Community of the University of Barcelona)(2012/02/23)
  • AGE, diabetes and its vascular complications(conference:International Conference on Diabetes and Metabolism 2012)(2012/11/09)

Arts and Fieldwork

Patent

Theme to the desired joint research

○Prevention of development of diabetic complications
○animal models of diabetic nephropathy
○Role of endogenous secretory RAGE (esRAGE) in human diseases
○Transporter of hormones
○Molecular mechanisms in the development of cancer stem-like cells
○Drugs targeting RAGE

Grant-in-Aid for Scientific Research

○「発生工学的手法を用いた糖尿病性血管合併症発症機構の解明」(2000-) 
○「発生工学的手法を用いた糖尿病性血管合併症発症機構の解明」(2001-) 
○「遺伝子ターゲティングによる糖尿病血管合併症の原因・治療の解明」(2002-) 
○「遺伝子ターゲティングによる糖尿病血管合併症の原因・治療の解明」(2003-) 
○「グライコミクスによる糖尿病合併症発症の新機序の解明」(2004-) 
○「グライコミクスによる糖尿病合併症発症の新機序の解明」(2005-) 
○「新しい機能性遺伝子同定技術の創出と成人病性血管障害関連遺伝子探索への応用」(2000-) 
○「糖化蛋白レセプター(RAGE)情報伝達系の解明―糖尿病性血管病変発生の新機構」(2001-) 
○「新規糖化蛋白質分子種による血管障害機序の解明」(2002-) 
○「多機能受容体RAGEのシグナリングネットワークの解明」(2004-) 
○「内在性分泌型RAGEタンパクの病原微生物に対する防御作用」(2004-) 
○「血管新生・糖尿病血管症罹患感受性を制御する選択的mRNAスプライシングの新機構」(2005-) 
○「マルチリガンド受容体RAGEによる細胞内シグナル生成機構の解明」(2006-) 
○「食品に含まれるRAGEシグナル阻害成分の同定と阻害機構の解明」(2014-2016)
○「スンクスにおける脂肪幹細胞の分布と分化能の解析」(2013-2016) 
○「関節リウマチ滑膜の上皮間葉移行の分子機構の解析と新規治療法への応用」(2015-2017) 
○「RAGEにより誘導される骨肉腫幹細胞モデルの確立とその分子機構の解明」(2015-2017) 
○「パターン認識受容体の切断により糖尿病血管合併症を制御する」(2012-2014) 
○「2型糖尿病の膵β細胞不全におけるRAGE・糖脂肪毒性・レプチンの役割の解明 」(2013-2016) 
○「新規血管保護因子-分泌型RAGEの発現機構と病態生理の解明」(2007-2010) 

Classes (Bachelors)

○Practical Medical Research(2017)
○Presentation and Debate (Freshman Seminar II)(2017)
○Introduction to Region-studies(2017)
○Presentation and Debate (Freshman Seminar II)(2017)
○Basic Health Science(2017)
○Biochemistry2(2017)
○Molecular Basis of the Cell Functions(2016)
○Basic Health Science(2016)
○Presentation and Debate (Freshman Seminar II)(2016)
○Introduction to Region-studies(2016)

Classes (Graduate Schools)

○Fostering the Independence of Researchers(2017)
○Molecular Biology of the Cardiovascular System(2017)
○BIOETHICS(2017)
○Molecular Biology of the Cardiovascular System(2017)
○Molecular Biology of the Cardiovascular System(2017)
○Introduction to Basic Medical Science(2016)
○Molecular Biology of the Cardiovascular System(2016)
○Molecular Biology of the Cardiovascular System(2016)
○Molecular Biology of the Cardiovascular System(2016)

International Project

International Students

Lecture themes

Others (Social Activities)

To Page Top